FindTrial
Sign In

A Novel Nomogram for Predicting Nonalcoholic Fatty Liver Disease in Bariatric Surgery Candidates

A Novel Nomogram for Predicting Nonalcoholic Fatty Liver Disease in Bariatric Surgery Candidates

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058462
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease

Interventions

Gold Standard:liver biopsy
Index test:Anthropometry (age, BMI, waist circumference), biochemical indicators (blood lipids, liver function, blood sugar, etc.), complications (hypertension, diabetes, etc.)

Sponsors

The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who met the indications for bariatric surgery and agreed to undergo liver biopsy.

Exclusion criteria

Exclusion criteria: Patients with hepatitis B or alcoholic fatty liver disease.

Design outcomes

Primary

MeasureTime frame
liver biopsy;serum lipid;biochemical parameters;—

Countries

China

Contacts

Public ContactCunchuan Wang

The First Affiliated Hospital of Jinan University

jnucwh2019@163.com+86 13129349492

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026